Find public sector tenders

NULL

Milton Keynes City Council ('the Council') is currently out to tender for the provision of a Medication Administration Service.

Central and North West London NHS Foundation Trust and Milton Keynes City Council are working together to commis ....

Secondary Care Medicines Price Optimisation (Dispensing Procurement). Software which allows Trusts to identify price differentials for medicines, ensuring that all purchases are made within agreed contract price points. Please note this will be procu ....

The Pharmaceutical Wholesale Services market continues to grow with new products becoming available and increasing demand with more patients being treated each year. With certain products only made available through specified pharmaceutical wholes ....

UKHSA is seeking to establish a contractual agreement with a pharmaceutical wholesaler for human medicines to act as a 3rd party on behalf of the Agency for the UK storage & distribution of vaccines, other medicines & associated medical pr ....

To supply unlicensed compounded medicinal products. Unlicensed compounded medicinal products are purchased to meet the clinical needs of patients for which no licensed medicine is available. Participating Trusts within the East Midlands have insuf ....

This tender is for medicines which are shortly due to lose their patent exclusivity, including but not limited to Eltrombopag, Ticagrelor and Ferric Carboxymaltose.

Health and Social Care Trusts (HSC) in Northern Ireland plan to tender for Unlicensed Medicines and Specials later this year. In order to assist with the development of a service specification and an appropriate methodology for the assessment of tend ....

NHS LPP is considering setting up a framework agreement or Dynamic Market for over-labelled medicines used in clinical and out-of-hours settings. Over-labelled medicines are typically used in settings like hospitals, prisons, community health serv ....

To provide a safe, cost effective framework for Imported Unlicensed Medicines – medicines originating into the UK which has marketing authorisation and is licensed in the country of origin but does not have a UK marketing authorisation. This framew ....